Register entry

NEXTPHARMA PLOERMEL

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Live patents
0
Countries
1
Base
France
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
NEXTPHARMA PLOERMELZONE INDUSTRIELLE DE CAMAGNON, PLOERMEL, 56800, France (FRA)Analytical testing, Finished drug manufacture3004298189493010524
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
capsule2
RouteNDCs
Labeller name on the listingNDCs
nextpharma ploermel2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-NORETHINDRONE ACETATE, ETHINYL ESTRADIOLcapsule52671-020DRUG FOR FURTHER PROCESSING
-icosapent ethylcapsule52671-001DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in France

Enquiry

Common questions

Is NEXTPHARMA PLOERMEL FDA approved?
NEXTPHARMA PLOERMEL holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are NEXTPHARMA PLOERMEL's drugs manufactured?
The FDA register lists PLOERMEL. Registered operations: analytical testing, finished drug manufacture.
What drugs does NEXTPHARMA PLOERMEL make?
2 products are listed under NEXTPHARMA PLOERMEL in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.